Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 40

1.

Risk factors for drug-resistant Streptococcus pneumoniae and antibiotic prescribing practices in outpatient community-acquired pneumonia.

Jenkins TC, Sakai J, Knepper BC, Swartwood CJ, Haukoos JS, Long JA, Price CS, Burman WJ.

Acad Emerg Med. 2012 Jun;19(6):703-6. doi: 10.1111/j.1553-2712.2012.01365.x. Epub 2012 May 25.

PMID:
22632455
[PubMed - indexed for MEDLINE]
2.

Drug treatment of pneumococcal pneumonia in the elderly.

Neralla S, Meyer KC.

Drugs Aging. 2004;21(13):851-64. Review.

PMID:
15493950
[PubMed - indexed for MEDLINE]
3.

Streptococcus pneumoniae: does antimicrobial resistance matter?

Lynch JP 3rd, Zhanel GG.

Semin Respir Crit Care Med. 2009 Apr;30(2):210-38. doi: 10.1055/s-0029-1202939. Epub 2009 Mar 18. Review.

PMID:
19296420
[PubMed - indexed for MEDLINE]
4.

[Guidelines for treatment of pneumonia in intensive care units].

Emmi V.

Infez Med. 2005;Suppl:7-17. Review. Italian.

PMID:
16801748
[PubMed - indexed for MEDLINE]
5.

Drug-resistant Streptococcus pneumoniae.

Campbell GD Jr, Silberman R.

Clin Infect Dis. 1998 May;26(5):1188-95. Review.

PMID:
9597251
[PubMed - indexed for MEDLINE]
Free Article
6.

The controversy of combination vs monotherapy in the treatment of hospitalized community-acquired pneumonia.

Weiss K, Tillotson GS.

Chest. 2005 Aug;128(2):940-6. Review.

PMID:
16100190
[PubMed - indexed for MEDLINE]
7.

Community-acquired pneumonia.

Cassiere HA, Niederman MS.

Dis Mon. 1998 Nov;44(11):613-75. Review.

PMID:
9858958
[PubMed - indexed for MEDLINE]
8.

Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.

Feldman C.

J Lab Clin Med. 2004 May;143(5):269-83. Review.

PMID:
15122171
[PubMed - indexed for MEDLINE]
9.

Clinical experience in the management of community-acquired pneumonia: lessons from the use of fluoroquinolones.

Carratalá J, Martín-Herrero JE, Mykietiuk A, García-Rey C.

Clin Microbiol Infect. 2006 May;12 Suppl 3:2-11. Review.

PMID:
16669924
[PubMed - indexed for MEDLINE]
10.

Escalation of antimicrobial resistance among Streptococcus pneumoniae: implications for therapy.

Lynch JP 3rd, Zhanel GG.

Semin Respir Crit Care Med. 2005 Dec;26(6):575-616. Review.

PMID:
16388429
[PubMed - indexed for MEDLINE]
11.

Principles of antibiotic treatment of community-acquired pneumonia in the outpatient setting.

Segreti J, House HR, Siegel RE.

Am J Med. 2005 Jul;118 Suppl 7A:21S-28S. Review.

PMID:
15993674
[PubMed - indexed for MEDLINE]
12.

Antimicrobial resistance and treatment of community-acquired pneumonia.

Mandell LA.

Clin Chest Med. 2005 Mar;26(1):57-64. Review.

PMID:
15802166
[PubMed - indexed for MEDLINE]
13.

Penicillin resistance in pneumococcal pneumonia. Antibiotics with low resistance potential are effective and pose less risk.

Cunha BA.

Postgrad Med. 2003 Jan;113(1):42-4, 47-8, 52-4. Review.

PMID:
12545592
[PubMed - indexed for MEDLINE]
14.

Elderly patients with community-acquired pneumonia: optimal treatment strategies.

Thiem U, Heppner HJ, Pientka L.

Drugs Aging. 2011 Jul 1;28(7):519-37. doi: 10.2165/11591980-000000000-00000. Review.

PMID:
21721597
[PubMed - indexed for MEDLINE]
15.

Pneumococcal antimicrobial resistance: therapeutic strategy and management in community-acquired pneumonia.

Aspa J, Rajas O, de Castro FR.

Expert Opin Pharmacother. 2008 Feb;9(2):229-41. doi: 10.1517/14656566.9.2.229 . Review.

PMID:
18201146
[PubMed - indexed for MEDLINE]
16.

Clinical implications and treatment of multiresistant Streptococcus pneumoniae pneumonia.

File TM Jr.

Clin Microbiol Infect. 2006 May;12 Suppl 3:31-41. Review.

PMID:
16669927
[PubMed - indexed for MEDLINE]
17.

Optimal therapy for severe pneumococcal community-acquired pneumonia.

Luján M, Gallego M, Rello J.

Intensive Care Med. 2006 Jul;32(7):971-80. Epub 2006 May 10. Review.

PMID:
16791660
[PubMed - indexed for MEDLINE]
18.

Streptococcus pneumoniae: epidemiology and patterns of resistance.

Jacobs MR.

Am J Med. 2004 Aug 2;117 Suppl 3A:3S-15S. Review.

PMID:
15360092
[PubMed - indexed for MEDLINE]
19.

Appropriate outpatient macrolide use in community-acquired pneumonia.

Gotfried MH.

J Am Acad Nurse Pract. 2004 Apr;16(4):146, 148, 150 passim. Review.

PMID:
15137473
[PubMed - indexed for MEDLINE]
20.

Role of beta-lactam agents in the treatment of community-acquired pneumonia.

Garau J.

Eur J Clin Microbiol Infect Dis. 2005 Feb;24(2):83-99. Review.

PMID:
15696306
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk